NEW YORK (GenomeWeb) – BioReference Laboratories today reported that its second quarter revenues increased 14 percent year over year, growth that it partly attributed to its genetics testing business.

The Elmwood Park, NJ-based clinical lab brought in total revenues of $201.4 million for the three months ended April 30, up from $176.5 million for the second quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.